6 On 30 April 2018, Hong Kong Exchanges and Clearing Limited added new listing rules, under Chapter 18A, to permit listings of biotech issuers that do not meet any of the Main Board financial eligibility tests. As of 30 September 2020, there is a cumulative of 40 biotech companies listed in Hong Kong under Chapter 18A.